Natixis Advisors’s Patterson-UTI PTEN Stock Holding History
Bought
Maintained
Sold
Other funds holding PTEN
SG
Natixis Advisors's PTEN Position: Q2 2026 in Review
Natixis Advisors reduced its Patterson-UTI (PTEN) stake by 10% in Q2 2026, selling an estimated $58.7K and leaving 45,407 shares worth $417K. The position accounts for ﹤0.01% of the portfolio, ranked #1729.
Natixis Advisors first reported a position in PTEN in Q2 2018 and has held it in 17 quarters since. The position peaked at $7.92M in Q1 2024. 438 funds tracked by Wall St. Rank hold PTEN as of Q2 2026.
- Natixis Advisors held 45,407 shares of Patterson-UTI worth $417K as of Q2 2026.
- Natixis Advisors sold 5,259 Patterson-UTI shares in Q2 2026, an estimated $58.7K.
- Patterson-UTI made up ﹤0.01% of Natixis Advisors's portfolio in Q2 2026, its #1729 holding.
- Natixis Advisors first reported a position in Patterson-UTI in Q2 2018 and has held it in 17 quarters since.
- Natixis Advisors's Patterson-UTI position peaked at $7.92M in Q1 2024.
- 438 funds tracked by Wall St. Rank held Patterson-UTI as of Q2 2026.
Based on Natixis Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.